3rd Next Generation Lipid-Based Nanoparticles Delivery Summit

Kongressthemen
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.

Kongressorganizer (PCO)
Hanson Wade Group

Anmerkungen
URL:
Brochure: https://go.evvnt.com/2315995-3?pid=4832

Speakers: Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, and more

https://go.evvnt.com/2315995-2?pid=4832

Frau Stephanie Nketia